Orbimed Advisors - GRAPHITE BIO INC ownership

GRAPHITE BIO INC's ticker is GRPH and the CUSIP is 38870X104. A total of 67 filers reported holding GRAPHITE BIO INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of GRAPHITE BIO INC
ValueSharesWeighting
Q3 2022$2,689,000
+15.3%
848,4120.0%0.05%
+19.0%
Q2 2022$2,333,000
-70.8%
848,412
-45.8%
0.04%
-67.4%
Q1 2022$7,986,000
-59.0%
1,565,8120.0%0.13%
-48.4%
Q4 2021$19,463,000
-18.1%
1,565,812
+8.0%
0.25%
-4.2%
Q3 2021$23,764,000
-30.1%
1,449,904
+31.1%
0.26%
-24.1%
Q2 2021$33,997,0001,106,3070.34%
Other shareholders
GRAPHITE BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 8,459,314$23,263,0006.20%
OUP Management Co., LLC 406,308$1,117,0001.54%
Privium Fund Management (UK) Ltd 344,567$948,0001.07%
Opaleye Management Inc. 460,000$1,265,0000.57%
TANG CAPITAL MANAGEMENT LLC 1,100,000$3,025,0000.46%
Board of Trustees of The Leland Stanford Junior University 703,071$1,933,0000.13%
Oasis Management Co Ltd. 255,102$702,0000.12%
K2 PRINCIPAL FUND, L.P. 401,675$1,105,0000.12%
EcoR1 Capital, LLC 1,162,179$3,196,0000.11%
Artal Group S.A. 700,000$1,925,0000.10%
View complete list of GRAPHITE BIO INC shareholders